Top Private Equity News, Member Posts, Managed Futures Daily Indices and more!

3yrs ago Private Equity privateequitywire Views: 388

Equistone exits Eschenbach Holding to Inspecs Group

Submitted 20/11/2020 - 10:09am

Funds advised by Equistone Partners Europe (Equistone) have agreed to sell their majority stake in Nuremberg-based Eschenbach Holding (Eschenbach), a German spcialist in eyewear and low-vision products, offering correction frames and ready-to-wear sunglasses, with further strong positions in Europe and the US. 

Eschenbach is being acquired by British Inspecs Group (Inspecs), which is based in Bath and listed in London. The financial terms of the transaction have not been disclosed and it remains subject to approval from the relevant competition authorities.

 
Founded in 1913, Eschenbach has developed into a global market leader for optical vision aids and one of the globally leading designers of branded glasses and optical products. Eschenbach combines award-winning design with reliable quality, whether with distinctive eyewear brands, magnifying vision aids or binoculars. This commitment to quality and design is also demonstrated by the multiple “Red Dot Awards” that Eschenbach has received for its eyewear collections in the past three years alone. According to Gesellschaft für Konsumforschung (GfK), the largest German market research institute, since the end of 2019, Eschenbach has become a leader in the German market for frames across all price segments.
 
Equistone (then Barclays Private Equity) acquired Eschenbach from the founding family and a financial investor in July 2007, together with the company’s management team. Since then, Eschenbach’s turnover has increased from an initial EUR 100 million to EUR 143 million in 2019. The strategic sale of its technical optics division in 2014 and the important acquisitions of British eyewear business International Eyewear Limited (2008) and US-based eyewear brand Tura (2009) also fell within this ownership period.
 
Inspecs was founded by Robin Totterman (CEO) in 1988 and is a designer, manufacturer and distributor of eyewear frames and lenses. The group produces a broad range of frames, covering optical, sunglasses and safety, which are either “Branded” (either under licence or under the Group’s own proprietary brands) or “OEM” (including private label on behalf of retail customers and unbranded). As one of only a few companies that can offer this one-stop-shop solution to global retail chains, Inspecs is well-positioned to continue to take market share in the globally expanding eyewear market. Inspecs customers include global optical and non-optical retailers, global distributors and independent opticians, with its distribution network covering over 80 countries and reaching approximately 30,000 points of sale. Inspecs has operations across the globe: with offices in the UK, Portugal, Scandinavia, the US and China (Hong Kong, Macau and Shenzhen), and manufacturing facilities in Vietnam, China, the UK and Italy.
 
“The successes we achieved during our partnership, as well as a very positive 2019 financial year and a new five-year growth strategy, form an ideal basis for Eschenbach’s continued, successful development. Joining forces with Inspecs will provide Eschenbach with an additional boost of momentum to reliably strengthen its global market position and to write a new chapter of its success story,” says Dr Marc Arens, Managing Director and Partner at Equistone’s Munich office.
 
“During our successful partnership, Equistone has always proved to be a reliable and growth-oriented investor and partner for more than a decade,” says Dr Jörg Zobel, CEO of Eschenbach. “Together with Equistone we found in Inspecs the right strategic partner for our new five-year growth vision. We have ambitious goals that we can achieve together in the new group. Our dedication to German engineering and quality and the best combination of design and function will remain key pillars.”
 
“We have followed Eschenbach’s progress for some time and are pleased to be welcoming Germany’s No1 eyewear company and its great people into the Inspecs Group. Joining these two industry-leading businesses together will create the sixth-largest eyewear company in the world and enable the enlarged Group to further penetrate key global markets while also diversifying our combined customer and product portfolios. This is an exciting time for the industry and I look forward to working together,” says Robin Totterman, CEO of Inspecs.
 

Tags Deals & Transactions Exits

Today's Private Equity Headlines:

Log In for More
Access Over 250K+ Industry Headlines, Posts and Updates
Not a member yet?

Join AlphaMaven

The Premier Alternative Investment
Research and Due Diligence Platform for Investors

Free Membership for Qualified Investors and Industry Participants
  • Easily Customize Content to Match Your Investment Preferences
  • Breaking News 24/7/365
  • Daily Newsletter & Indices
  • Alternative Investment Listings & LeaderBoards
  • Industry Research, Due Diligence, Videos, Webinars, Events, Press Releases, Market Commentary, Newsletters, Fact Sheets, Presentations, Investment Mandates, Video PitchBooks & More!
  • Company Directory
  • Contact Directory
  • Member Posts & Publications
  • Alpha University Video Series to Expand Investor Knowledge
  • AUM Accelerator Program (designed for investment managers)
  • Over 450K+ Industry Headlines, Posts and Updates
ALL ALPHAMAVEN CONTENT IS FOR INFORMATIONAL PURPOSES ONLY. CONTENT POSTED BY MEMBERS DOES NOT NECESSARILY REFLECT THE OPINION OR BELIEFS OF ALPHAMAVEN AND HAS NOT ALWAYS BEEN INDEPENDENTLY VERIFIED BY ALPHAMAVEN. PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS. THIS IS NOT A SOLICITATION FOR INVESTMENT. THE MATERIAL PROVIDED HEREIN IS FOR INFORMATIONAL PURPOSES ONLY. IT DOES NOT CONSTITUTE AN OFFER TO SELL OR A SOLICITATION OF AN OFFER TO BUY ANY INTERESTS OF ANY FUND OR ANY OTHER SECURITIES. ANY SUCH OFFERINGS CAN BE MADE ONLY IN ACCORDANCE WITH THE TERMS AND CONDITIONS SET FORTH IN THE INVESTMENT'S PRIVATE PLACEMENT MEMORANDUM. PRIOR TO INVESTING, INVESTORS ARE STRONGLY URGED TO REVIEW CAREFULLY THE PRIVATE PLACEMENT MEMORANDUM (INCLUDING THE RISK FACTORS DESCRIBED THEREIN), THE LIMITED PARTNERSHIP AGREEMENT AND THE SUBSCRIPTION DOCUMENTS, TO ASK SUCH QUESTIONS OF THE INVESTMENT MANAGER AS THEY DEEM APPROPRIATE, AND TO DISCUSS ANY PROSPECTIVE INVESTMENT IN THE FUND WITH THEIR LEGAL AND TAX ADVISERS IN ORDER TO MAKE AN INDEPENDENT DETERMINATION OF THE SUITABILITY AND CONSEQUENCES OF AN INVESTMENT.